|
Rescue Medications Clinical Trials
7 actively recruiting trials across 5 locations
Pipeline
Phase 2: 2Phase 3: 2Phase 1/2: 3
Top Sponsors
- Merck Sharp & Dohme LLC7
Indications
- Cancer7
- Lung Cancer3
- Gastroesophageal Junction1
- Gastroesophageal Adenocarcinoma1
- Lung Neoplasm Malignant1
Miami Beach, Florida2 trials
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
Mount Sinai Comprehensive Cancer Center ( Site 6000)
Phase 3
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
Mount Sinai Cancer Center ( Site 0029)
Phase 3
Other1 trial
Anchorage, Alaska1 trial
A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)
Alaska Womens Cancer Care ( Site 0037)
Phase 2
Tucson, Arizona1 trial
Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)
University of Arizona Cancer Center-University of Arizona Cancer Center ( Site 8927)
Phase 1/2
Clermont, Florida1 trial
A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)
Clermont Oncology Center ( Site 0041)
Phase 1/2
Lexington, Kentucky1 trial
Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)
University of Kentucky Chandler Medical Center ( Site 0019)
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.